Treatment of Patients With Nocturia (Non-PK Study)

NCT00937378 · clinicaltrials.gov ↗

PHASE3

Phase

COMPLETED

Status

326

Enrollment

INDUSTRY

Sponsor class

Conditions

Nocturia

Interventions

DRUG: SER120
DRUG: Placebo

Sponsor

Serenity Pharmaceuticals, Inc.